Pregunta 1
Pregunta
What’s the most common type of heart disease, and leading cause of death?
Pregunta 2
Pregunta
There are two major categories of stroke. 80% are which one?
Pregunta 3
Pregunta
Platelets are disc-shaped fragments produced by __________.
Respuesta
-
Megakaryotes
-
Megakaryocytes
-
Minikaryocytes
-
Minikaryotes
-
Spleen
-
Blasts
Pregunta 4
Pregunta
Average platelet count is:
Respuesta
-
150,000 – 400,000 / μL
-
150 – 400 / μL
-
1,500 – 4,000 / μL
-
15,000 – 40,000 / μL
-
150,000 – 40,000 / μL
Pregunta 5
Pregunta
Which of the following are functional responses of platelets?
Respuesta
-
Primary adhesion
-
Shape change
-
Aggregation
-
Granule release
-
Procoagulant function
-
Anticoagulant function
-
Secondary adhesion
-
Antiapoptotic function
-
Proapoptotic function
-
Carry Oxygen
Pregunta 6
Pregunta
Shape change is a crucial functional response of platelets to …something. They change shape from [blank_start]__________[blank_end] to [blank_start]__________[blank_end]
Respuesta
-
Flat disc
-
Spiny disc
-
Spiny sphere
-
Smooth sphere
Pregunta 7
Pregunta
Which receptor/ligand interactions occur during which bit?
Respuesta
-
GPIb/V/IX – vWF
-
αIibβ3 – fibronectin, VWF
-
αIibβ3 – fibrinogen, fibronectin
-
GPIb/V/IX – vWF
-
αIibβ3 – fibronectin, VWF
-
αIibβ3 – fibrinogen, fibronectin
-
GPIb/V/IX – vWF
-
αIibβ3 – fibronectin, VWF
-
αIibβ3 – fibrinogen, fibronectin
Pregunta 8
Pregunta
Fibrin generation at the site of vascular injury has a crucial role in anchoring the thrombus to the vessel. It requires initiation of coagulation and generation of thrombin. This depends on Tissue Factor (TF) expression on the surface of [blank_start]__________[blank_end] and fibroblasts.
Respuesta
-
Smooth Muscle Cells (SMCs)
-
Vascular Endothelial Cells (VECs)
-
Vascular Epithelial Cells (VECs)
-
Skeletal Muscle Cells (SMCs)
-
Cardiac Muscle Cells (CMCs)
Pregunta 9
Pregunta
Platelet-mediated fibrin clot retraction shrinks the size of the blood clot. Thought to be important for stabilising the clot against shear forces of blood flow. This requires:
Respuesta
-
Integrin αIIbβ3
-
Fibrin
-
Myosin/contractile force
-
Actin cytoskeleton
Pregunta 10
Pregunta
Which of the following are prothrombotic and which are antithrombotic?
ADP: [blank_start]__________[blank_end];
Aspirin: [blank_start]__________[blank_end];
Epinephrine: [blank_start]__________[blank_end];
Clopidogrel: [blank_start]__________[blank_end];
Collagen: [blank_start]__________[blank_end];
Heparin: [blank_start]__________[blank_end];
Thrombin: [blank_start]__________[blank_end];
Respuesta
-
Pro
-
Anti
-
Anti
-
Pro
-
Pro
-
Anti
-
Anti
-
Pro
-
Pro
-
Anti
-
Anti
-
Pro
-
Pro
-
Anti
Pregunta 11
Pregunta
Does Aspirin prevent initial platelet adhesion?
Pregunta 12
Pregunta
Does Aspirin prolong skin bleeding time?
Pregunta 13
Pregunta
What’s the efficacy of Aspirin?
Respuesta
-
~5-10%
-
~15%
-
~25%
-
~30-50%
-
~50-70%
-
~75%
-
~85%
-
~90-95%
Pregunta 14
Pregunta
Does Aspirin inhibit prostacyclin synthesis?
Pregunta 15
Pregunta
Does Aspirin stimulate prostacyclin synthesis?
Pregunta 16
Pregunta
Does Aspirin suppress the release of thrombogenic factors from platelets?
Pregunta 17
Pregunta
Integrin αIibβ3 (GPIIbIIIa) inhibitors are:
Respuesta
-
Antithrombotic (but can cause severe bleeding)
-
Prothrombotic (but can cause severe bleeding)
-
Antithrombotic (but can't cause severe bleeding)
-
Prothrombotic (but can't cause severe bleeding)
Pregunta 18
Pregunta
Which of the following are CURRENT (not further potential) antithrombotic treatments:
Pregunta 19
Pregunta
PAR antagonists are under development as a potential novel antithrombotic. What’s PAR?
Respuesta
-
Protease-Activated Receptor
-
Protease-Antigen Receptor
-
Protease-Antagonist Receptor
-
Protease-Agonist Receptor
-
Protease-Activating Receptor